Loading...
Loading...
BAX| Name | Value |
|---|---|
| Revenues | 3,649.0M |
| Cost of Revenue | 2,302.0M |
| Gross Profit | 1,347.0M |
| Operating Expense | 1,161.0M |
| Operating I/L | -132.0M |
| Other Income/Expense | 202.0M |
| Interest Income | 10.0M |
| Pretax | 70.0M |
| Income Tax Expense | 25.0M |
| Net Income/Loss | 44.0M |
Baxter International Inc. develops and provides a wide range of healthcare products and services globally. The company's offerings include dialysis therapies, intravenous therapies, drug platforms, anesthesia and critical care products, pharmacy compounding services, parenteral nutrition therapies, surgical products, continuous renal replacement therapies, and connected care solutions. Baxter also provides integrated patient monitoring and diagnostic technologies, surgical video technologies, and contracted services to pharmaceutical and biopharmaceutical companies. Its products are utilized in various healthcare settings, including hospitals, dialysis centers, nursing homes, and patients' homes under physician supervision. The company distributes its products through direct sales, independent distributors, drug wholesalers, and specialty pharmacy providers in around 100 countries.
